• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adenocarcinoma Presenting as Pulmonary Ground Glass Opacities (GGOs): Every GGO Has Its Own Story.

作者信息

Aprile Vittorio, Mastromarino Maria Giovanna, Korasidis Stylianos, Ambrogi Marcello Carlo, Lucchi Marco

机构信息

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

Thoracic Surgery Unit. University Hospital of Pisa, Pisa, Italy.

出版信息

Ann Surg Oncol. 2025 Mar 11. doi: 10.1245/s10434-025-17116-z.

DOI:10.1245/s10434-025-17116-z
PMID:40069463
Abstract
摘要

相似文献

1
Adenocarcinoma Presenting as Pulmonary Ground Glass Opacities (GGOs): Every GGO Has Its Own Story.表现为肺部磨玻璃影（GGO）的腺癌：每个GGO都有其自身的情况。
Ann Surg Oncol. 2025 Mar 11. doi: 10.1245/s10434-025-17116-z.
2
Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?磨玻璃影的处理：所有伴磨玻璃影的肺部病变都应手术切除吗？
Transl Lung Cancer Res. 2013 Oct;2(5):354-63. doi: 10.3978/j.issn.2218-6751.2013.09.03.
3
Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT.细支气管肺泡癌和具有细支气管肺泡特征的腺癌在CT上表现为磨玻璃影。
Clin Imaging. 2002 Mar-Apr;26(2):95-100. doi: 10.1016/s0899-7071(01)00372-2.
4
Surgical therapy of ground-glass opacities.磨玻璃影的外科治疗
Semin Diagn Pathol. 2014 Jul;31(4):289-92. doi: 10.1053/j.semdp.2014.06.006. Epub 2014 Jun 12.
5
EGFR Mutation Rates Correlate with Age at Diagnosis and Tumor Characteristics in Patients with Pulmonary Ground-Glass Opacities.肺磨玻璃影患者的表皮生长因子受体（EGFR）突变率与诊断时的年龄及肿瘤特征相关。
Ann Surg Oncol. 2024 Dec 25. doi: 10.1245/s10434-024-16730-7.
6
Pregnancy may have little influence on ground-glass opacities suspected for lung adenocarcinoma.怀孕可能对疑似肺腺癌的磨玻璃影影响不大。
J Cancer Res Clin Oncol. 2023 Apr;149(4):1383-1389. doi: 10.1007/s00432-022-03999-y. Epub 2022 Apr 20.
7
[Surgery for Pulmonary Multiple Ground Glass Opacities].[肺部多发性磨玻璃影的外科治疗]
Zhongguo Fei Ai Za Zhi. 2016 Jun 20;19(6):355-8. doi: 10.3779/j.issn.1009-3419.2016.06.11.
8
Genomic landscape of ground glass opacities (GGOs) in East Asians.东亚地区磨玻璃影（GGOs）的基因组特征
J Thorac Dis. 2021 Apr;13(4):2393-2403. doi: 10.21037/jtd-21-82.
9
Invasiveness and malignant potential of pulmonary lesions presenting as pure ground-glass opacities.表现为纯磨玻璃影的肺病变的侵袭性和恶性潜能
Ann Thorac Cardiovasc Surg. 2014;20(5):347-52. doi: 10.5761/atcs.oa.13-00005. Epub 2013 Oct 3.
10
Long-term results after surgical treatment of the dominant lung adenocarcinoma associated with ground-glass opacities.伴有磨玻璃影的优势肺腺癌手术治疗后的长期结果
J Thorac Dis. 2018 Aug;10(8):4838-4848. doi: 10.21037/jtd.2018.07.21.

本文引用的文献

1
Outcomes of Laparoscopic Radical Hysterectomy in Ia1-Ib1 Cervical Cancer Patients: A Multi-Center Study with 10 Years' Experiences in the Real World.Ia1-Ib1期宫颈癌患者腹腔镜根治性子宫切除术的结局：一项具有10年真实世界经验的多中心研究
Ann Surg Oncol. 2025 Mar;32(3):2213-2222. doi: 10.1245/s10434-024-16637-3. Epub 2024 Dec 29.
2
Prognostic impact of targetable driver alterations in resected early-stage lung cancer.可靶向驱动基因改变对可切除早期肺癌的预后影响
Transl Lung Cancer Res. 2024 Nov 30;13(11):3096-3105. doi: 10.21037/tlcr-24-433. Epub 2024 Nov 14.
3
Imaging diagnostics of pulmonary ground-glass nodules: a narrative review with current status and future directions.
肺磨玻璃结节的影像学诊断：现状与未来方向的叙述性综述
Quant Imaging Med Surg. 2024 Aug 1;14(8):6123-6146. doi: 10.21037/qims-24-674. Epub 2024 Jul 18.
4
Different clinicopathological features between young and older patients with pulmonary adenocarcinoma and ground-glass opacity.肺腺癌伴磨玻璃影患者的不同临床病理特征与年龄的关系。
Sci Rep. 2024 Jul 8;14(1):15679. doi: 10.1038/s41598-024-66910-4.
5
Prevalence of EGFR Mutations in Patients With Resected Stages I to III NSCLC: Results From the EARLY-EGFR Study.早期 EGFR 研究：Ⅰ期至Ⅲ期 NSCLC 患者中 EGFR 突变的流行率。
J Thorac Oncol. 2024 Oct;19(10):1449-1459. doi: 10.1016/j.jtho.2024.06.008. Epub 2024 Jun 14.
6
Prognostic and predictive value of interstitial lung abnormalities and EGFR mutation status in patients with non-small cell lung cancer.非小细胞肺癌患者肺间质异常和 EGFR 突变状态的预后和预测价值。
Cancer Imaging. 2024 May 23;24(1):66. doi: 10.1186/s40644-024-00712-9.
7
Endobronchial ultrasound-transbronchial needle aspiration: effectiveness and accuracy in non-small cell lung cancer staging.经支气管超声引导针吸活检术：在非小细胞肺癌分期中的有效性和准确性。
Updates Surg. 2024 Sep;76(5):1909-1918. doi: 10.1007/s13304-024-01777-8. Epub 2024 Mar 11.
8
Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures.表皮生长因子受体突变型非小细胞肺癌（NSCLC）的治疗：成功之路，铺满失败。
Pharmacol Ther. 2017 Jun;174:1-21. doi: 10.1016/j.pharmthera.2017.02.001. Epub 2017 Feb 4.